TY - GEN A1 - Ecke, Alexander A1 - Bell, Jérémy A1 - Schneider, Rudolf T1 - From Laboratory Immunoassays to Immunosensors with an Integrated Microfluidic Flow System N2 - This research summary describe efforts to the development of a three-dimensional microfluidic flow cell for improved electrochemical substrate detection in HRP/TMB-based immunoassays. This work provides a valuable advancement in the sensitivity and integration of immunoassay technologies, aiding in the refinement of diagnostic tools. KW - Antikörper KW - Immunoassay KW - Microfluidics KW - Electrochemical detection KW - Biosensor PY - 2025 UR - https://www.elveflow.com/microfluidics-research-summaries/from-laboratory-immunoassays-to-immunosensors-with-an-integrated-microfluidic-flow-system/ SP - 1 EP - 4 CY - Paris AN - OPUS4-62674 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - CONF A1 - Schneider, Rudolf A1 - Konthur, Zoltán A1 - Jaeger, Carsten T1 - Reference Material (IgG) for CCQM-PAWG Key Comparison N2 - BAM proposes a recombinant human IgG (anti-tetanus monoclonal antibody SA13) as candidate material for the 2027 CCQM-PAWG key comparison on antibody purity. The antibody is produced via hybridoma and recombinant expression systems, with detailed sequence and glycosylation profiling. Analytical methods include MALDI-TOF-MS, SEC, DLS, and UV-vis spectroscopy to assess purity, aggregation, and stability. Preliminary results show high purity, low heterogeneity, and consistent size distribution. A minimum of 40 mg IgG is required, with 100 mg preferred for deeper characterization. Production is expected to be completed by the end of 2026, with potential for a joint technical project. T2 - Spring Meeting of CCQM-PAWG CY - Sèvres, France DA - 06.04.2025 KW - Antibodies KW - Research Grade Test Material KW - Mass spectrometry KW - Affinity PY - 2025 AN - OPUS4-63503 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - CONF A1 - Schneider, Rudolf T1 - Monitoring trace substances in wastewater and surface water by immunoanalytical assays and sensors N2 - Monitoring the elimination of trace substances in wastewater treatment plants, as required in the recast of the EU Urban Wastewater Treatment Directive and the new Kommunalabwasserrichtlinie (KARL), creates a need for on-site analyses in wastewater treatment plants. Immunoanalytical methods can be carried out on site, e.g. in the form of rapid tests, but continuously operating (immuno-bio)sensors would be ideal. And antibody-based methods have the inherent disadvantage that one antibody must be used per analyte and therefore only a small number of substances can be analysed. A set of indicators has been integrated in the directives in accordance with the list of the Kompetenzzentrum Spurenstoffe BW (KomS) and offer points of reference here. Yet, in order to be able to use immunoanalytical methods for their monitoring, (DIN/ISO) standards are required that define the necessary quality requirements and quality management measures for the sensors. In addition, for the larger part of the indicators, the required antibodies have yet to be developed and made commercially available in the long term. The talk will highlight our previous work on high-throughput methods, such as ELISA, regarding the presence of anthropogenic markers and some indicators as well as research approaches for sensor technology that could be used on-site, and will provide an overview of deficits and future efforts. T2 - Kolloquium der Abteilung Technische Umweltchemie und Sensortechnik CY - Stuttgart, Germany DA - 21.05.2025 KW - Antibodies KW - Immunoassay KW - Microfluidics KW - Biosensor KW - Trace substances PY - 2025 AN - OPUS4-63501 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - CONF A1 - Schneider, Rudolf T1 - Bestimmung von Spurenstoffen im (Roh-)Abwasser mittels ELISA N2 - Der Vortrag behandelt die Bestimmung von Spurenstoffen im Rohabwasser mithilfe von ELISA (Enzyme-Linked Immunosorbent Assay), einer immunanalytischen Methode, die sich durch hohe Sensitivität und Eignung für Hochdurchsatzanalysen auszeichnet. Im Rahmen der Projekte MARKERIA I & II wurden verschiedene anthropogene Marker wie Koffein, Carbamazepin, Diclofenac, Bisphenol A und Hormone wie Östron untersucht, um deren Eignung für die Abwassersurveillance zu bewerten. Die Ergebnisse zeigen, dass einige Substanzen wie Carbamazepin stabile Konzentrationen aufweisen und sich gut als Marker eignen, während andere wie Koffein starke Schwankungen zeigen. Einige Marker wie Isolithocholsäure werden zwar in hohen Konzentrationen gefunden, zeigen aber methodische Herausforderungen wie instabile Assays. Die Studie hebt hervor, dass es Hotspots mit erhöhten Konzentrationen gibt, aber insgesamt eine relativ geringe Variabilität zwischen verschiedenen Rohabwässern besteht. Zukünftige Entwicklungen sollen sich auf die Verbesserung von Antikörpern, die Entwicklung tragbarer Vor-Ort-Analysemethoden und die Standardisierung immunanalytischer Verfahren konzentrieren. T2 - AMELAG-Colloquium "Spurenstoffe im (Ab-)Wasser" CY - Online meeting DA - 20.06.2025 KW - Antikörper KW - Schnelltests KW - Abwasser KW - ELISA PY - 2025 AN - OPUS4-63500 LA - deu AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - GEN A1 - Schneider, Rudolf T1 - Wasserdiagnose durch die Verwendung von Markern N2 - Die Überwachung des gesamten Wasserkreislaufs auf Mikroverunreinigungen ist aus gesundheitlicher und ökologischer Hinsicht wünschenswert und gewinnt durch den Klimawandel und das zunehmende Erfordernis der Wiederverwendung des Brauchwassers weiter an Bedeutung. Die schnellen und kostengünstigen antikörperbasierten Methoden („Immunoassays“) können helfen, Informationslücken zu schließen und kürzere Reaktionszeiten zu ermöglichen. Von Labormethoden über tragbare Analysengeräte bis hin zu Online-Sensoren sind viele Formate möglich (u. a. ELISA, Abb. 1). Es muss zudem die Bereitstellung der notwendigen, hochqualitativen Antikörper gewährleistet werden. Da aber gilt „1 Analyt – 1 Antikörper“, ist die Herstellung eines Konsenses bezüglich der vordringlich zu bestimmenden Indikatoren/Marker notwendig. Auch die Normung der Verfahren ist parallel in Angriff zu nehmen. KW - Antikörper KW - Immunoassay KW - Abwasser KW - ELISA PY - 2025 UR - https://analyticalscience.wiley.com/content/article-do/wasserdiagnose-durch-die-verwendung-von-markern VL - 2025 IS - 1 SP - 1 EP - 4 PB - WILEY CY - Hoboken, NJ, USA AN - OPUS4-63508 LA - deu AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - CONF A1 - Schneider, Rudolf T1 - Keeping the Y N2 - The talk traces my career path and presents BAM as an attractive employer. It also offers advice on shaping one's own career after PhD. T2 - IWC Alumni Day 2025 CY - Garching bei München, Germany DA - 04.07.2025 KW - Antibodies KW - ELISA KW - Career PY - 2025 AN - OPUS4-63640 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - CONF A1 - Schneider, Rudolf T1 - Immunochemical sensing of key pollution indicators in the water cycle N2 - Organic micropollutants - often termed emerging contaminants - are increasingly detected throughout the water cycle, from drinking water to wastewater. Monitoring their distribution requires trace analytical methods that are fast, cost-effective, matrix-tolerant, and ideally portable. Immunoanalytical techniques, using antibodies, nanobodies, or fragments, offer high selectivity and sensitivity, though typically in single-analyte or oligoplexing formats. To maximize their utility, environmentally relevant indicator compounds should be selected to reflect pollutant input, partial removal during treatment, and persistence in wastewater and surface water. ELISA remains a robust method for high-throughput analysis. We have assays available for the com-pounds carbamazepine, diclofenac, cetirizine, estrone, sulfamethoxazole, caffeine, cocaine, bisphenol A, and isolithocholic acid. Simpler formats like fluorescence polarization immunoassays (FPIA) and lateral flow immunoassays (LFIA)—familiar from COVID-19 rapid tests — enable on-site screening. Multiplexing is feasible with bead-based microarrays and electrochemical sensors on microfluidic platforms, which additionally offer portability and the latter even independence from optical systems. Despite these advances, the development of highly selective, high-affinity binders remains a critical bottleneck. Promising strategies to overcome this include computational hapten design, nanobody engineering, and in silico optimization of binder sequences—enhanced by artificial intelligence for targeted database mining. These approaches, coupled with scalable recombinant expression, are poised to expand the binder repertoire essential for any immunoanalytical platform. This growing repository will be key to advancing immunochemical diagnostics across the water cycle. T2 - 5th International Symposium on Nanobody for Immunological Analysis and Application CY - Guangzhou, China DA - 15.11.2025 KW - Antibodies KW - Immunoassay KW - Microfluidics KW - Biosensor KW - Trace substances KW - Electrochemical detection PY - 2025 AN - OPUS4-64923 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - CONF A1 - Schneider, Rudolf T1 - How can antibodies help us in the risk assessment of pharmaceuticals in the environment? N2 - The widespread use of pharmaceuticals has led to their persistent presence in various environmental compartments, raising concerns about ecological and human health risks since they pose a significant threat to non-target organisms and human health, necessitating robust methods for environmental risk assessment.   Traditional analytical methods, such as liquid chromatography-mass spectrometry (LC-MS), offer high sensitivity and specificity but are often resource-intensive, require complex sample preparation, limiting their applicability for large-scale or real-time monitoring. In this context, antibody-based analytical techniques present a promising complementary approach for the detection and quantification of pharmaceutical residues in environmental matrices.   Antibodies, due to their high specificity and affinity, enable the development of immunoassays such as ELISA, lateral flow assays, fluorescence-based formats, and electrochemical sensors that are rapid, cost-effective, and adaptable to field conditions. These methods can be tailored to target a wide range of pharmaceutical compounds, including antibiotics and endocrine disruptors. Moreover, antibody-based assays facilitate high-throughput screening and can be integrated into portable platforms for on-site analysis, thereby enhancing temporal and spatial resolution in environmental monitoring.   This presentation explores the potential of antibodies in environmental risk assessment, focusing on their application in detecting trace levels of pharmaceuticals in water, soil, and biota. They are presented as a complementary and powerful tool for rapid, cost-effective screening in the lab and that also can be deployed for on-site analysis in the field.   The talk also discusses recent advances in antibody engineering, multiplexing capabilities [1], and the integration of immunoassays with sensor technologies [2].   Case studies illustrate how immunoanalytical data can help in finding potential contamination hotspots [3], hazard identification, pollution source tracking, and the generation of crucial data for predictive models on environmental fate and effects. Antibody-based methods can also help in early warning systems and the evaluation of mitigation strategies, contributing to a more comprehensive and proactive risk assessment framework, eventually to regulatory decision-making, ultimately aiding in the protection of ecosystems and public health. T2 - ICRAPHE - 6th International Conference on Risk Assessment of Pharmaceuticals in the Environment CY - Aveiro, Portugal DA - 20.10.2025 KW - Antibodies KW - Immunoassay KW - Microfluidics KW - Electrochemical detection KW - Biosensor PY - 2025 AN - OPUS4-64922 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Devi, Sarita A1 - Riedel, Soraya A1 - Döring, Sarah A1 - Hiller, Lukas A1 - Kaliyaraj Selva Kumar, Archana A1 - Flemig, Sabine A1 - Singh, Chandan A1 - Konthur, Zoltán A1 - Hodoroaba, Vasile-Dan A1 - Schneider, Rudolf T1 - Antibodies Functionalized Magnetic Fe-Metal-Organic Framework Based Biosensor for Electrochemical Detection of Tetanus Neurotoxin N2 - This work presents a metal-organic framework (MOF)-integrated microfluidic flow-cell (MFC) based immunodetection of the tetanus toxoid (TT) using electrochemical technique for the first time. The magnetic property of Fe-MOF helped to hold them on the working electrode at detection zone of MFC surpassing the requirement of additional conjugation chemistry, whereas the conductive property was utilized to observe the change in signal efficiency in the presence of TT. The one-pot hydrothermal synthesis of a magnetic and conductive iron-based MOF (Fe-MOF) was performed using the Fe3 +/Fe2+ precursors as 1.2/1 mmol and dual ligands, i.e., tetrahydroxy-1,4-benzoquinone and 2-aminobenzene-1,4-dicarboxylic acid. The Fe-MOF was conjugated with L-phenylalanine (Fe-MOF/Phe) to increase its electric conductivity owing to the enhanced electron flow rate. The human monoclonal antibody SA13 against TT (anti-TT mAb) was conjugated on the Fe-MOF/Phe surface with the help of ethylenediamine (Fe-MOF/Phe/EDA/anti-TT mAb). The binding affinity of Fe-MOF/Phe/EDA/anti-TT mAb for the TT antigen was evaluated using cyclic voltammetry technique. The limit of detection of the Fe-MOF/Phe/EDA/anti-TT mAb-based biosensor for TT was 9.4 ng/ml in spiked buffer. This study shows the applicability of these Fe-MOFs in the detection of various other microbial toxins or other biomolecules. KW - Antikörper KW - Elektrochemischer Immunoassay KW - Molecular Organic Framework (MOF) KW - Microfluidics KW - Rekombinant PY - 2025 DO - https://doi.org/10.1016/j.snb.2025.137381 SN - 0925-4005 VL - 431 SP - 1 EP - 12 PB - Elsevier B.V. CY - Amsterdam AN - OPUS4-62673 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Schneider, Rudolf T1 - Antikörperbasierte vor-Ort-Analytik für das Monitoring der Eliminierung von Spurenstoffen in Kläranlagen N2 - Die Überwachung der Eliminierung von Spurenstoffen in Kläranlagen, wie sie die Neufassung der Kommunalabwasserrichtlinie vorschreibt, ruft einen Bedarf an vor-Ort-Analytik in den Kläranlagen hervor. Immunanalytische Methoden können vor Ort, z.B. in Form von Schnelltests, durchgeführt werden, ideal aber wären kontinuierlich arbeitende (Immuno-Bio)Sensoren. Antikörperbasierte Verfahren weisen als Flaschenhals immanent die Einschränkung auf, dass pro Analyt ein Antikörper zum Einsatz kommen muss und dass daher nur eine kleinere Anzahl von Substanzen analysiert werden kann. Die Indikatorenliste der Abwasserrichtlinie liefert hier einen Anhaltspunkt. Der Artikel weist schon bisher existierende Schnell- und Hochdurchsatzverfahren aus, ebenso wie Forschungsansätze für eine Sensorik, die online einsetzbar wäre und gibt einen Überblick über Defizite und Entwicklungen. KW - Antikörper KW - Immunoassay KW - Schnelltests KW - Biosensor PY - 2025 SN - 1618-3258 VL - 31 IS - 1 SP - 12 EP - 14 AN - OPUS4-63510 LA - deu AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -